menu ☰
menu ˟

Acucela, University of Manchester enter licensing agreement for gene therapy

05 Apr 2016
Acucela has entered into an exclusive licensing agreement with the University of Manchester to develop and commercialize the university’s human rhodopsin-based optogenetic gene therapy to treat retinitis pigmentosa and related conditions, according...

Click here to view the full article which appeared in Opthalmology

IPH Logo